Most women undergo breast cancer screening but only around half are undergoing bowel cancer screening Related items fromOnMedica Experts call for wider HPV vaccination NHS cancer screening programmes set for major review Cancer strategies failed to improve one-year survival Third of emergency cancer presenters never saw GP New cervical cancer test outperforms existing tests
This study investigated feasibility and safety of a prehabilitation program for colorectal cancer.
Multimodal prehabilitation was offered to patients eligible for participation and they were assigned to an intervention or control group by program availability. The prehabilitation program consisted of the following four interventions: in-hospital high-intensity endurance and strength training, high-protein nutrition and supplements, smoking cessation, and psychological support. Program attendance, patient satisfaction, adverse events, and functional capacity were determined.
Fifty patients participated…
CONCLUSIONS: Hospital serosurveillance as described is an option to monitor the impact of vaccination on the population. Our experience could be reproduced in other regions under similar conditions if the above-mentioned challenges are solved.
PMID: 31529840 [PubMed – in process]
Bayer data at ESMO 2019 highlights innovation in cancer researchNew data for larotrectinib on durability of response in patients with TRK fusion cancer to be presented in a poster discussion on September 28 / Data from Bayer’s prostate cancer franchise to be presented, including clinical relevance of drug-drug interactions in men with nmCRPC taking darolutamide and real-world data and pain evalutation data in men with mCRPC treated with radium-223 dichloride / New analyses from the Phase II study REGOBONE evaluating the efficacy and safety of regorafenib in patients with rare locally advanced or metastatic relapsed chondro…
In this study, we used qualitative methods to better understand the changes in sexual life and related care strategies for breast cancer survivors. Twenty interviews were conducted on clinical patients enrolled in hospitals that received breast cancer treatment. The data were analysed by performing a constant comparative analysis. Three themes emerged: the causes of changes in sexual life, internal response strategies and external response strategies. Ten subthemes were identified. Changes in sexual life in patients with breast cancer in this study included changes related to body image, influence of friends and family, ag…
SAN DIEGO – Photon-counting CT scanners might not yet be available for everyday…Read more on AuntMinnie.comRelated Reading:
Dedicated breast CT shows promise for cancer screening
Photon-counting breast CT shows promise
ISCT: New CT detectors promise sharper images
NIH begins clinical use of photon-counting CT
MDCT: Future CT scanners will deliver more image, less noise
This report summarises evidence on the management of four screening programmes in England: bowel cancer, breast cancer, cervical cancer and abdominal aortic aneurysm. The report finds that the Department of Health and Social Care, NHS England and Public Health England are not doing enough to make sure that everyone who is eligible to take part in screening is doing so, and do not know if everyone who should be invited for screening has been
Conclusion A scaled community health worker workforce integrated into primary care may be a valuable policy alternative. Pilot studies are required to establish feasibility and impact in NHS primary care.
PMID: 30286301 [PubMed – as supplied by publisher]
Concerns expressed that opportunities to save lives may be missedCancer patients in the UK may not receive enough follow-up after a diagnosis, a new study by researchers in Chicago suggests.The study, presented at the annual American Society of Clinical Oncology in Chicago, suggests five years of monitoring is insufficient for some cancers and too long for others. The research suggests some NHS patients may receive too few years of follow-up care.Continue reading…
Among the drugs de-listed as a result of cuts to the Cancer Drugs Fund are those to treat breast cancer, multiple myeloma, bowel cancer, pancreatic cancer, cervical cancer and leukaemia.
Data from Cancer Research UK suggests 80% of patients survive for at least 10 years after being diagnosed in early stages of eight of most common cancersThe survival rate for people with eight of the most common cancers is more than three times higher when the disease is diagnosed early, Cancer Research UK said on Monday.Data for thousands of patients between 1996 and 2000 suggests just over 80% of those with cancer survive for at least 10 years when their disease is diagnosed at stage one or two but only a quarter of those diagnosed at stage three or four live for at least a decade more. Continue reading…